These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10151016)

  • 1. Restenosis after coronary angioplasty.
    Anderson HV; Vignale SJ; Benedict CR; Willerson JT
    J Interv Cardiol; 1993 Sep; 6(3):187-202. PubMed ID: 10151016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restenosis after coronary angioplasty.
    Anderson HV
    Dis Mon; 1993 Sep; 39(9):613-70. PubMed ID: 8359109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis following coronary angioplasty: clinical presentations and therapeutic options.
    Levine GN; Chodos AP; Loscalzo J
    Clin Cardiol; 1995 Dec; 18(12):693-703. PubMed ID: 8608668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemia: reperfusion injury and restenosis after coronary angioplasty.
    Park JW; Braun P; Mertens S; Heinrich KW
    Ann N Y Acad Sci; 1992 Sep; 669():215-36. PubMed ID: 1444028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis following coronary angioplasty.
    Karas SP; Santoian EC; Gravanis MB
    Clin Cardiol; 1991 Oct; 14(10):791-801. PubMed ID: 1954687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis after percutaneous transluminal coronary angioplasty--anatomic and pathophysiological mechanisms. Strategies for prevention.
    Block PC
    Circulation; 1990 Mar; 81(3 Suppl):IV2-4. PubMed ID: 2407372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine.
    Tanabe Y; Ito E; Nakagawa I; Suzuki K
    Int J Cardiol; 2001 May; 78(3):285-91. PubMed ID: 11376832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
    Harker LA
    Am J Cardiol; 1987 Jul; 60(3):20B-28B. PubMed ID: 2956836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilesion coronary angioplasty: clinical and angiographic follow-up.
    Vandormael MG; Deligonul U; Kern MJ; Harper M; Presant S; Gibson P; Galan K; Chaitman BR
    J Am Coll Cardiol; 1987 Aug; 10(2):246-52. PubMed ID: 2955019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of restenosis after successful coronary angioplasty: improved clinical decision making with use of a logistic model combining procedural and follow-up variables.
    Renkin J; Melin J; Robert A; Richelle F; Bachy JL; Col J; Detry JM; Wijns W
    J Am Coll Cardiol; 1990 Nov; 16(6):1333-40. PubMed ID: 2229783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The clinical and angiographic evolution of dilated lesions in the proximal segment of the anterior descending coronary artery: stent versus balloon].
    Marcos-Alberca Moreno P; Iñíguez Romo A; Navarro del Amo F; Serrano Antolín JM; Ibargollín Hernández R; García Belenguer R; de la Paz J
    Rev Esp Cardiol; 1999 Mar; 52(3):181-8. PubMed ID: 10193171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
    Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
    Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.
    Hirshfeld JW; Schwartz JS; Jugo R; MacDonald RG; Goldberg S; Savage MP; Bass TA; Vetrovec G; Cowley M; Taussig AS
    J Am Coll Cardiol; 1991 Sep; 18(3):647-56. PubMed ID: 1869725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
    Hombach V; Waltenberger J; Voisard R; Höher M
    Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty.
    Kotamäki M; Laustiola K; Syvänne M; Heikkilä J
    J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.
    Gottsauner-Wolf M; Sochor H; Hornykewycz S; Beckmann R; Lang I; Probst P; Binder BR; Huber K
    Thromb Haemost; 1999 Apr; 81(4):522-6. PubMed ID: 10235432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.
    de Groote P; Bauters C; McFadden EP; Lablanche JM; Leroy F; Bertrand ME
    Circulation; 1995 Feb; 91(4):968-72. PubMed ID: 7850983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of restenosis after successful percutaneous coronary angioplasty by dobutamine thallium-201 scintigraphy.
    Caner B; Oto A; Ovunc K; Kiratli P
    Int J Cardiol; 1998 Sep; 66(2):175-81. PubMed ID: 9829332
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.